English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52582408    線上人數 :  780
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"lin c c"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 556-565 / 2549 (共255頁)
<< < 51 52 53 54 55 56 57 58 59 60 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-07-13T06:04:32Z Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors Liao B.-C.; Bai Y.-Y.; LEE JIH-HSIANG; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏 2021-07-13T06:04:30Z Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; LEE JIH-HSIANG; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2021-07-13T06:04:29Z A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors LEE JIH-HSIANG; Chen T.W.-W.; Hsu C.-H.; Yen Y.-H.; Yang J.C.-H.; Cheng A.-L.; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; Lin C.-C.
臺大學術典藏 2021-07-13T06:04:28Z Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours de Bono J.; Lin C.-C.; Chen L.-T.; Corral J.; Michalarea V.; Rihawi K.; Ong M.; LEE JIH-HSIANG; Hsu C.-H.; Yang J.C.-H.; Shiah H.-S.; Yen C.-J.; Anthoney A.; Jove M.; Buschke S.; Fuertig R.; Schmid U.; Goeldner R.-G.; Strelkowa N.; Huang D.C.-L.; Bogenrieder T.; Twelves C.; Cheng A.-L.
臺大學術典藏 2021-07-13T06:04:27Z Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; LEE JIH-HSIANG; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2021-07-12T08:46:26Z EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer HSIANG-FONG KAO; Lin C.-C.; Yang J.C.-H.
臺大學術典藏 2021-07-08T01:23:52Z Persistent endodontic lesion due to complex cementodentinal tears in a maxillary central incisor-a case report Tai T.-F.; Chiang C.-P.; Lin C.-P.; Lin C.-C.; JIIANG-HUEI JENG
臺大學術典藏 2021-07-08T01:23:51Z Horizontal/oblique root fractures in the palatal root of maxillary molars with associated periodontal destruction: Case reports Lin C.C.; Tsai Y.L.; Li U.M.; Chang Y.C.; Lin C.P.; JIIANG-HUEI JENG
臺大學術典藏 2021-07-08T01:23:51Z Transforming Growth Factor β2 Regulates Growth and Differentiation of Pulp Cells via ALK5/Smad2/3 Tai T.-F.; Chan C.-P.; Lin C.-C.; Chen L.-I.; JIIANG-HUEI JENG; Chang M.-C.
臺大學術典藏 2021-07-08T01:23:49Z The effect of BisGMA on cyclooxygenase-2 expression, PGE2 production and cytotoxicity via reactive oxygen species- and MEK/ERK-dependent and -independent pathways Chang M.-C.; Lin L.-D.; Chan C.-P.; Chang H.-H.; Chen L.-I.; Lin H.-J.; Yeh H.-W.; Tseng W.-Y.; Lin P.-S.; Lin C.-C.; JIIANG-HUEI JENG

顯示項目 556-565 / 2549 (共255頁)
<< < 51 52 53 54 55 56 57 58 59 60 > >>
每頁顯示[10|25|50]項目